Diadema Partners »

Arcturus Therapeutics Hldg I shares owned by Diadema Partners

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.7M 200k 18.43

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
BlackRock
Balyasny Asset Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Vanguard Group
ARK Investment Management
State Street Corporation
Susquehanna International
Schonfeld Strategic Advisors
Geode Capital Management
Morgan Stanley
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
Caption Management

View all funds holding Arcturus Therapeutics Hldg I